Combination of thalidomide and cisplatin in an head and neck squamous cell carcinomas model results in an enhanced antiangiogenic activity in vitro and in vivo. [electronic resource]
Producer: 20071029Description: 1697-704 p. digitalISSN:- 0020-7136
- Angiogenesis Inhibitors -- pharmacology
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Carcinoma, Squamous Cell -- blood supply
- Cell Movement -- drug effects
- Cell Proliferation -- drug effects
- Cisplatin -- administration & dosage
- Disease Models, Animal
- Drug Synergism
- Female
- Germ-Free Life
- Head and Neck Neoplasms -- blood supply
- Immunohistochemistry
- Mice
- Mice, Inbred NOD
- Mice, SCID
- Microcirculation -- drug effects
- Thalidomide -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.